CIOReview named Flagship Biosciences “Company of the Year,” as part of the publication’s 2018 20 Most Promising Pharma & Life Sciences Tech Solution Providers industry review.
“The ease of leveraging Flagship’s powerful solution is yet another massive differentiator of the company. Clients need not have to change their existing workflows, investments in technology, or even the assays that they use.” ~ CIOReview, November, 2018
“We make existing tissue-based assays more powerful predictive diagnostics by adding significantly more data from our cTA® platform. Our goal is to empower physicians with a scorecard that ensures the right drug gets to the right patient,” says Trevor Johnson, Flagship CEO.
CIOReview is a leading resource for innovative IT solutions. The award article highlights Flagship’s robust cTA platform and centralized, full-service solutions that streamline every step of immuno-oncology therapy development.